Skip to main content
. Author manuscript; available in PMC: 2020 Oct 19.
Published in final edited form as: Curr Pharm Des. 2013;19(5):833–840.

Fig. (2).

Fig. (2).

MET TK domain constructs, wildtype or harboring either the D1246H, Y1248H, or M1268T mutation (all previously detected in renal cancer), were transfected into MCF-7 cells. Transfected cells were treated with the TKI BMS777607 and Western blot analysis was performed using a c-Met or phoshorylated c-Met antibody. The Y1248H mutant was shown to be most sensitive.